| Literature DB >> 27138438 |
Arvin K George1, Baris Turkbey2,3, Subin G Valayil2, Akhil Muthigi2, Francesca Mertan2,3, Michael Kongnyuy2, Peter A Pinto2.
Abstract
Prostate cancer is unique in that unlike other solid organ malignancies, only recently has imaging been employed to routinely detect and localize disease. The introduction of transrectal ultrasound was a significant development, transitioning digitally guided prostate biopsies to ultrasound guidance. The arrival of multiparametric MRI has become the next major step, transforming the way Urologist's diagnose, stage, and treat prostate cancer. Recent recommendations against PSA screening have changed the landscape of urologic oncology with the changing needs being reflected in the initiation of additional robust imaging techniques at different time points in prostate cancer care. The current review aims to provide a clinical perspective in the history, current standard of care, and novel imaging modalities in the evaluation of prostate cancer.Entities:
Keywords: Cancer diagnosis; Image-guided biopsy; Imaging; Prostate cancer; Staging
Mesh:
Year: 2016 PMID: 27138438 PMCID: PMC7815163 DOI: 10.1007/s00261-016-0751-6
Source DB: PubMed Journal: Abdom Radiol (NY)